DXP ENTERPRISES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data DXP ENTERPRISES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	962	1,007	1,219	1,265	1,005	1,114	1,481	1,679	1,802	2,016
Cost of revenue	697	735	883	915	728	785	1,059	1,173	1,246	1,380
Gross profit	265	272	336	350	277	329	422	505	556	636
Selling, general and administrative	245	238	264	282	245	289	324	367	411	459
General and administrative				48.9	57	65.9	60.1	71.4	83.5	87.9
Operating income	19.3	33.5	72.1	67.4	-27.7	39.9	97.8	139	145	177
Interest expense	15.6	17.1	20.9	19.5	20.6	21.1	29.1	53.1	63.9	60.5
Interest income							0.19	2.68	4.77	3.58
Other non-operating income	5.91	0.46	1.19	0.05	-0.07	0.41	-2.72	1.36	3.52	2.88
Pre-tax income	9.67	16.9	52.3	48	-48.3	19.2	65.9	86.9	85	119
Income tax	2.52	0.36	14.1	11.2	-18.7	3.43	17.8	18.1	14.5	30.5
Net income to minority interests	-0.55	-0.36	-0.11	-0.26	-0.35	-0.75	-0.05	0	0
Net income	7.7	16.9	38.3	37	-29.3	16.5	48.2	68.8	70.5	88.7
EBITDA	49.3	44	81.7	77.5	-17.3	49.8	107	147	154	187
EPS, basic	0.59	1.13	2.18	2.10	-1.65	0.87	2.58	4.07	4.44	5.65
EPS, diluted	0.57	1.08	2.08	2.01	-1.65	0.83	2.47	3.89	4.22	5.37
Shares, basic (weighted)	13	15	17.6	17.6	17.7	18.9	18.6	16.9	15.9	15.7
Shares, diluted (weighted)	13.7	15.7	18.4	18.4	17.7	19.8	19.5	17.7	16.7	16.5

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	1.59	22	40.3	54.2	119	49	46	173	148	304
Receivables	149	167	196	189	167	218	321	311	339	398
Inventory	83.7	91.4	116	130	97.1	101	101	104	103	108
Other current assets	2.14	5.3	4.94	4.22	4.55	9.52	24.1	18	20.3	47
Total current assets	257	318	386	409	409	405	516	649	662	910
Property, plant and equipment	60.8	53.3	51.3	63.7	56.9	51.9	46	61.6	81.6	115
Lease right-of-use assets			0	66.2	55.2	57.2	57.4	48.7	46.6	74.7
Goodwill	188	188	194	194	250	297	334	344	452	495
Intangible assets	94.8	78.5	67.2	52.6	80.1	79.2	79.6	63.9	85.7	81.4
Other non-current assets	1.5	1.72	1.78	3.21	4.76	4.81	4.46	10.6	21.5	9.4
Total assets	602	639	704	789	868	894	1,037	1,177	1,349	1,685
Accounts payable	78.7	80.3	80.1	63.7	64.8	77.8	92.8	96.5	104	117
Accrued liabilities	17	18.5	21.3	23.4	20.6	23	26.3	36.2	41.7	51.2
Deferred revenue		4.25	10.7	11.9	4.06	3.58	10.4	9.51	12.7	15.7
Short-term debt	51.4	3.38	3.41	2.5	3.3	3.3	4.37	5.5	6.6	8.58
Total current liabilities	167	125	143	139	147	181	213	224	244	272
Long-term debt	173	239	237	235	317	315	409	521	622	818
Lease liabilities			0	48.6	38	39.9	40.2	34.3	33.2	57.5
Other non-current liabilities		0	2.82	1.21	2.93	3.6	9.59	17.4	27.9	38.3
Total liabilities	350	371	386	434	507	548	672	797	927	1,187
Total debt	225	242	240	238	330	319	414	526	628	827
Paid-in capital	152	153	156	158	192	207	214	216	220	221
Retained earnings	117	134	179	216	186	202	251	319	390	478
Treasury stock	0				0	-33.5	-67.8	-124	-153	-170
Other comprehensive income	-18.3	-19.5	-19.3	-20	-18	-29.3	-31.7	-31.2	-33.6	-30.6
Shareholders' equity	252	268	307	354	360	347	365	381	423	498
Minority interests	0.93	0.57	1.41	1.15	0.8	0.05	0
Total equity	253	275	317	343	349	347	365	381	423	498
Total liabilities and equity	602	639	704	789	868	894	1,037	1,177	1,349	1,685
Shares outstanding	14.8	14.9		17.6	19.2	18.6	17.7	16.2	15.7	15.5

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	7.15	16.5	38.2	36.8	-29.6	15.8	48.1	68.8	70.5	88.7
Depreciation and amortization	30	10.5	9.58	10.1	10.4	9.95	9.59	8.42	9.02	10.4
Stock-based compensation	3.58	1.71	2.55	1.96	3.53	1.82	1.85	3.07	4.71	5.71
Deferred income tax	2.69	-3.83	1	0.84	-14.7	6.14	-7.54	-9.06	-15	26.8
Change in receivables	12.1	-20.5	-25	7.9	44.9	-43.7	-93.9	13.3	-12.6	-41.5
Change in inventory	5.45	-7.54	-21.4	-13.9	22.4	-5.29	2.07	-2.03	8.43	1.04
Change in payables	-8.6	3.19	7.42	-19	-15.3	27	36	10.6	7.55
Cash from operations	48.2	12.5	35.8	41.3	110	37.1	5.89	106	102	94.3
Capital expenditures	-4.87	-2.81	-9.32	-22.1	-6.67	-6	-4.92	-12.3	-25.1	-40.3
Acquisitions	0	0	-10.8	0	-115	-64.7	-48.5	-10.4	-157	-61.7
Cash from investing	27.8	-2.81	-17.6	-22.1	-122	-69	-53.4	-22.6	-182	-99.2
Debt issued	518	729	0	0	330	0	105	550	650	848
Debt repaid	-644	-702	-3.38	-4.34	-244	-3.3	-3.57	-430	-550	-643
Stock issued	51.9	0	0	0	1.14	0	0
Share buybacks	0	0		0	0	-33.5	-47.9	-56.2	-29	-17.1
Dividends paid	-0.09	-0.09	-0.09	-0.09	-0.09	-0.09	-0.09	-0.09	-0.09	-0.09
Cash from financing	-76.1	14.2	-2.92	-6.09	77.4	-38.5	44.3	43.6	56.8	159
Exchange rate effect	-0.09	0.07	-0.4	0.68	-0.17	0.09	0.25	-0.06	-2.12	1.49
Net change in cash	-0.1	24	14.9	13.8	65.1	-70.3	-2.96	127	-24.8	155
Free cash flow	43.4	9.73	26.5	19.2	103	31.1	0.98	94	77.1	54
Interest paid	13.7	15.2	19.1	17.6	13.3	19.5	25.3	49	67	53.7
Income taxes paid	4.78	0.71	8.3	13.3	6.28	6.12	26.2	20.6	18.7	36.4

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $192.10 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	31.8%	Gross profit / revenue.
Operating margin	8.8%	Operating income / revenue.
EBITDA margin	9.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.9%	Pre-tax income / revenue.
Net margin	4.4%	Net income / revenue.
FCF margin	5.5%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	6.3%	Cash from operations / revenue.
Effective tax rate	26.5%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	17.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	5.3%	Net income / average total assets.
Return on invested capital (ROIC)	12.1%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	23.0%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.3%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.7%	Capital expenditures / revenue.
D&A / revenue	0.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	11.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	10.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	14.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	14.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	14.6%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	18.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	21.7%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	21.9%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	21.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	20.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	25.8%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	22.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	27.3%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	29.5%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-7.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	151.9%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-3.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-30.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	280.7%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-12.1%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	17.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	10.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	6.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	24.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	17.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	14.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-5.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.99x	Current assets / current liabilities.
Quick ratio	2.24x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.76x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.53x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	46.6%	Total debt / total assets.
Liabilities / assets	69.4%	Total liabilities / total assets.
Net debt	$598.3M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.99x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	2.92x	Operating income / interest expense.
Working capital	$591.9M	Current assets - current liabilities.
Goodwill and intangibles / assets	38.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$136.2M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.21x	Revenue / average total assets.
Fixed asset turnover	17.8x	Revenue / average property, plant and equipment.
Inventory turnover	12.0x	Cost of revenue / average inventory.
Days inventory	30 days	365 x average inventory / cost of revenue.
Receivables turnover	4.86x	Revenue / average receivables.
Days sales outstanding	75 days	365 x average receivables / revenue.
Days payables	33 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	72 days	Days inventory + days sales outstanding - days payables.
FCF conversion	127.4%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	11.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.70	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$130.88	Revenue / diluted weighted shares.
FCF per share	$7.26	Free cash flow / diluted weighted shares.
Operating cash flow per share	$8.23	Cash from operations / diluted weighted shares.
Book value per share	$34.88	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$8.79	Tangible book value / shares outstanding.
Cash per share	$14.62	(Cash + short-term investments) / shares outstanding.
Payout ratio	0.1%	Dividends paid / net income, when net income is positive.
Dividends / FCF	0.1%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$2.98B	Share price x shares outstanding.
Enterprise value	$3.58B	Market cap + total debt - cash - short-term investments.
P/E	32.0x	Market cap / net income. Only when net income is positive.
P/S	1.39x	Market cap / revenue.
P/B	5.51x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	25.1x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	22.1x	Market cap / cash from operations, when positive.
EV/Sales	1.67x	Enterprise value / revenue.
EV/EBIT	19.0x	Enterprise value / operating income, when both are positive.
EV/EBITDA	17.9x	Enterprise value / EBITDA, when both are positive.
EV/FCF	30.2x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.0%	Free cash flow / market cap.
Earnings yield	3.1%	Net income / market cap (the inverse of P/E).
Dividend yield	0.0%	Dividends paid over the period / market cap.
Shareholder yield	0.0%	(Dividends paid + share buybacks) / market cap.
PEG	1.08x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was DXP ENTERPRISES INC's revenue in fiscal 2025?

DXP ENTERPRISES INC reported revenue of $2.02B for fiscal 2025, 11.9% higher than the year before.

Was DXP ENTERPRISES INC profitable in fiscal 2025?

Yes. Net income was $88.7M, a net margin of 4.4%.

How much free cash flow did DXP ENTERPRISES INC generate in fiscal 2025?

Cash from operations of $94.3M minus capital expenditures of $40.3M left free cash flow of $54.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to DXP ENTERPRISES INC